Full-Time

Research Scientist

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Accelerates antibody drug discovery with data science

Data & Analytics
AI & Machine Learning
Biotechnology

Senior

Vancouver, BC, Canada

Required Skills
Communications
Data Analysis
Requirements
  • Working with our highly motivated team on projects related to the identification of high-quality antibodies. The scope of the work may include the development of in vitro assays that include various mammalian cell lines and primary cells, design of in vivo experiments, development of media conditions and/or enrichment strategies for primary cells, and design of complex functional assays
  • Optimizing and troubleshooting the development of screening assays for high-throughput antibody discovery and antibody validation
  • Developing assays and cutting-edge technologies for antibody discovery against challenging targets
  • Designing, planning, and executing experiments, either independently or in collaboration with your teammates
  • Analyzing and presenting data to colleagues and partners
  • Solving problems at a high level
  • Liaising with partners and communicating project updates and deliverables
  • Training, mentoring and supervising members of a dynamic team
  • Maintaining and implementing standard operating procedures while recognizing opportunities for improvements and innovation
  • Organizing, supporting and collaborating with other team members to meet project deliverables and timelines
  • Post-doc or PhD in relevant field, or MSc plus at least 5 years work experience in relevant field
  • Demonstrated experience in cell biology and data analysis
  • Experience with mammalian cell culture and cell-based assay development
  • Excellent communication and presentation skills
  • Excellent documentation and organizational skills
  • Impeccable attention to detail
  • Proven interpersonal skills with the ability to work collaboratively
  • Strong leadership skills
  • Experience in immunology, infectious disease, development of antibody-based assays, flow cytometry or microscopy (optional, but desired)

AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

16%

2 year growth

77%
INACTIVE